• Abo SM, Debari VA 2007 Laboratory evaluation of the antiphospholipid syndrome. Ann. Clin. Lab. Sci. 37: 3-14.

• Abu Romeh IS, Chhatriwalla AK, Atik FA, Bhatt DL, Navia JL 2007 Myocardial infarction secondary to a coronary ostial thrombus in antiphospholipid syndrome. Ann. Thorac. Surg. 83: 1170-1171.

• Al Attia HM, Santhosh A 2007 A probe into the HLA-DR and DQ of Arab patients with primary antiphospholipid (Hughes) syndrome. Rheumatol. Int. 28: 193-195. *

• Alessandri C, Bombardieri M, Di Prospero L, Conigliaro P, Conti F, Labbadia G, Misasi R, Sorice M, Valesini G 2005 Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus. Clin. Exp. Immunol. 140: 173-180. *

• Alessandri C, Bombardieri M, Valesini G 2006 Pathogenic mechanisms of anti-endothelial cell antibodies (AECA): their prevalence and clinical relevance. Adv. Clin. Chem. 42: 297-326.

• Alessandri C, Sorice M, Bombardieri M, Conigliaro P, Longo A, Garofalo T, Manganelli V, Conti F, Esposti ED, Valesini G 2006 Anti-phospholipid reactivity against cardiolipin metabolites occurring during endothelial cell apoptosis. Arthritis Res. Ther. 8: R180. *

• Alijotas-Reig J, Casellas-Caro M, Ferrer-Oliveras R, Llurba-Olive E, Hermosilla E, Vilardell-Tarres M, Cabero-Roura L 2008 Are anti-beta-glycoprotein-I antibodies markers for recurrent pregnancy loss in lupus anticoagulant/anticardiolipin seronegative women? Am. J. Reprod. Immunol. 60: 229-237. *

• Alpert D, Mandl LA, Erkan D, Yin W, Peerschke EI, Salmon JE 2008 Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome. Ann. Rheum. Dis. 67: 395-401.

• Amin NM 2008 Antiphospholipid syndromes in infectious diseases. Hematol. Oncol. Clin. North Am. 22: 131-143.

• Amital H, Govoni M, Maya R, Meroni PL, Ori B, Shoenfeld Y, Tincani A, Trotta F, Sarzi-Puttini P, Atzeni F 2008 Role of infectious agents in systemic rheumatic diseases. Clin. Exp. Rheumatol. 26: S27-S32.

• Andreoli L, Malacarne F, Ceribelli A, Kutschera I, Tincani A 2007 Anti-cardiolipin and anti-beta2-glycoprotein I antibodies: performance of new commercial ELISA kits. Ann. N. Y. Acad. Sci. 1109: 531-537.

• Andreoli L, Pregnolato F, Burlingame RW, Allegri F, Rizzini S, Fanelli V, Radice A, Corace C, Sinico RA, Meroni PL, Tincani A 2008 Antinucleosome antibodies in primary antiphospholipid syndrome: a hint at systemic autoimmunity? J. Autoimmun. 30: 50-56. *

• Araki Y, Sakaguchi C, Ishizuka I, Sasaki M, Tsujikawa T, Koyama S, Furukawa A, Fujiyama Y 2005 Budd-Chiari syndrome: a case with a combination of hepatic vein and superior vena cava occlusion. World J. Gastroenterol. 11: 3797-3799. *

• Arkfeld DG 2008 The potential utility of B cell-directed biologic therapy in autoimmune diseases. Rheumatol. Int. 28: 205-215. *

• Aronovich R, Gurwitz D, Kloog Y, Chapman J 2005 Antiphospholipid antibodies, thrombin and LPS activate brain endothelial cells and Ras-dependent pathways through distinct mechanisms. Immunobiology 210: 781-788.

• Asherson RA 2005 Multiorgan failure and antiphospholipid antibodies: the catastrophic antiphospholipid (Asherson's) syndrome. Immunobiology 210: 727-733. *

• Asherson RA 2006 The catastrophic antiphospholipid (Asherson's) syndrome. Autoimmun. Rev. 6: 64-67.

• Asherson RA 2005 The catastrophic antiphospholipid (Asherson's) syndrome in 2004 - a review. Autoimmun. Rev. 4: 48-54. *

• Asherson RA, Bosman C, Tikly M, Spiro F, Pope FM 2006 Ehlers-Danlos syndrome type IV in a young man. J. Rheumatol. 33: 2091-2096.

• Asherson RA, Cervera R 2003 Unusual manifestations of the antiphospholipid syndrome. Clin. Rev. Allergy Immunol. 25: 61-78.

• Asherson RA, Frances C, Iaccarino L, Khamashta MA, Malacarne F, Piette JC, Tincani A, Doria A 2006 The antiphospholipid antibody syndrome: diagnosis, skin. Clin. Exp. Rheumatol. 24: S46-S51.

• Asherson RA, Greenblatt MA 2001 Recurrent alveolar hemorrhage and pulmonary capillaritis in the "primary" antiphospholipid syndrome. J. Clin. Rheumatol. 7: 30-33.

• Aspinall AI, Lee SS 2004 Concurrence of primary biliary cirrhosis and antiphospholipid antibody syndrome. Am. J. Gastroenterol. 99: 2069-2070. *

• Atanassova PA 2007 Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview. Yonsei Med. J. 48: 901-926. *

• Ates Y, Aslan M, Tuzun A, Bagci S, Dagalp K 2004 Ulcerative colitis case beginning during pregnancy in a patient with antiphospholipid antibody syndrome. Turk. J. Gastroenterol. 15: 263-265. *

• Atsumi T, Amengual O, Yasuda S, Koike T 2004 Antiprothrombin antibodies-are they worth assaying? Thromb. Res. 114: 533-538. *

• Audia S, Duchene C, Samson M, Muller G, Bielefeld P, Ricolfi F, Giroud M, Besancenot JF 2008 Stroke in young adults with celiac disease. Rev. Med. Interne. 29: 228-231.

• Austin SK, Starke RD, Lawrie AS, Cohen H, Machin SJ, Mackie IJ 2008 The VWF/ADAMTS13 axis in the antiphospholipid syndrome: ADAMTS13 antibodies and ADAMTS13 dysfunction. Br. J. Haematol. 141: 536-544.

• Avcin T 2008 Antiphospholipid syndrome in children. Curr. Opin. Rheumatol. 20: 595-600.

• Avcin T, Canova M, Guilpain P, Guillevin L, Kallenberg CG, Tincani A, Tonon M, Zampieri S, Doria A 2008 Infections, connective tissue diseases and vasculitis. Clin. Exp. Rheumatol. 26: S18-S26.

• Bachmeyer C, Barrier A, Frazier A, Fulgencio JP, Lecomte I, Grateau G, Callard P 2006 Diffuse large and small bowel necrosis in catastrophic antiphospholipid syndrome. Eur. J. Gastroenterol. Hepatol. 18: 1011-1014.

• Balderramo DC, Garcia O, Colmenero J, Espinosa G, Forns X, Gines P 2008 Antiphospholipid syndrome during pegylated interferon alpha-2a therapy for chronic hepatitis C. Dig. Liver Dis. Jan 31 [Epub ahead of print].

• Bar-Sela S, Shoenfeld Y 2008 Photocopy machines and occupational antiphospholipid syndrome. Isr. Med. Assoc. J. 10: 52-54. *

• Barak N, Orion Y, Schneider M, Bernheim J, Mekori YA 1999 Case report: Hepatic involvement in antiphospholipid syndrome. J. Gastroenterol. Hepatol. 14: 1124-1128. *

• Barnabe CC, Leclercq SA, Fitzgerald AA 2008 The development of inflammatory arthritis and other rheumatic diseases following stem cell transplantation. Semin. Arthritis Rheum. May 31 [Epub ahead of print]. *

• Barzilai O, Sherer Y, Ram M, Izahaky D, Anaya JM, Shoenfeld Y 2007 Epstein-Barr virus and cytomegalovirus in autoimmune diseases. Are they truly notorious? A preliminary report. Ann. N. Y. Acad. Sci. 1108: 567-577. *

• Bayraktar UD, Erkan D, Bucciarelli S, Espinosa G, Asherson R 2007 The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus. J. Rheumatol. 34: 346-352.

• Becker-Merok A, Nossent H 2005 Antiphospholipid antibody syndrome in autoimmune hepatitis. Isr. Med. Assoc. J. 7: 268-269.

• Benten D, Widjaja A, von Depka M, Flemming P, Trautwein C, Boker K, Vogel A, Rosenau J, Manns MP 2001 Autoimmune hepatitis associated with coagulation disorders and immunethyreopathy. Z. Gastroenterol. 39: 837-840.

• Berkun Y, Gershwin ME, Shoenfeld Y 2005 Autoimmune hepatitis: a part of the antiphospholipid syndrome? Isr. Med. Assoc. J. 7: 264-265.

• Berkun Y, Kenet G 2008 Pediatric antiphospholipid syndrome. Isr. Med. Assoc. J. 10: 45-47. *

• Berkun Y, Padeh S, Barash J, Uziel Y, Harel L, Mukamel M, Revel-Vilk S, Kenet G 2006 Antiphospholipid syndrome and recurrent thrombosis in children. Arthritis Rheum. 55: 850-855. *

• Bernales I, Fullaondo A, Marin-Vidalled MJ, Ucar E, Martinez-Taboada V, Lopez-Hoyos M, Zubiaga AM 2008 Innate immune response gene expression profiles characterize primary antiphospholipid syndrome. Genes Immun. 9: 38-46. *

• Bertolaccini ML, Khamashta MA 2006 Laboratory diagnosis and management challenges in the antiphospholipid syndrome. Lupus 15: 172-178.

• Bertolaccini ML, Khamashta MA, Hughes GR 2005 Diagnosis of antiphospholipid syndrome. Nat. Clin. Pract. Rheumatol. 1: 40-46. *

• Bidot CJ, Jy W, Horstman LL, Ahn ER, Yaniz M, Ahn YS 2006 Antiphospholipid antibodies (APLA) in immune thrombocytopenic purpura (ITP) and antiphospholipid syndrome (APS). Am. J. Hematol. 81: 391-396. *

• Black A 2006 Antiphospholipid syndrome: an overview. Clin. Lab. Sci. 19: 144-147.

• Bladt V, Steengaard-Pedersen K, Poulsen LH, Petersen OB, Laursen B, d'Amore F 2004 Late puerperal thrombohemorrhagic complications in a patient with antiphospholipid syndrome. Eur. J. Haematol. 73: 437-440. *

• Blank M, Anafi L, Zandman-Goddard G, Krause I, Goldman S, Shalev E, Cervera R, Font J, Fridkin M, Thiesen HJ, Shoenfeld Y 2007 The efficacy of specific IVIG anti-idiotypic antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model. Int. Immunol. 19: 857-865.

• Blank M, Aron-Maor A, Shoenfeld Y 2005 From rheumatic fever to Libman-Sacks endocarditis: is there any possible pathogenetic link? Lupus 14: 697-701.

• Blank M, Krause I, Magrini L, Spina G, Kalil J, Jacobsen S, Thiesen HJ, Cunningham MW, Guilherme L, Shoenfeld Y 2006 Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome. Rheumatology (Oxford) 45: 833-841. *

• Blank M, Nur I, Toub O, Maor A, Shoenfeld Y 2005 Toward molecular targeting with specific intravenous immunoglobulin preparation. Clin. Rev. Allergy Immunol. 29: 213-218.

• Blank M, Shani A, Goldberg I, Kopolovic J, Amigo MC, Magrini L, Shoenfeld Y 2004 Libman-Sacks endocarditis associated with antiphospholipid syndrome and infection. Thromb. Res. 114: 589-592. *

• Bonaci-Nikolic B, Andrejevic S, Bukilica M, Urosevic I, Nikolic M 2006 Autoantibodies to mitotic apparatus: association with other autoantibodies and their clinical significance. J. Clin. Immunol. 26: 438-446. *

• Braham A, Safer L, Bdioui F, Lejmi A, Brahmi I, Ben Chabenne N, Ben Mimoun H, Saffar H 2001 Antiphospholipid antibodies in digestive diseases. Presse Med. 30: 1890-1897.

• Branger S, Schleinitz N, Veit V, Martaresche C, Bourliere M, Roblin X, Garcia S, San Marco M, Camoin L, Durand JM, Harle JR 2007 Auto-immune hepatitis and antiphospholipids. Rev. Med. Interne. 28: 218-224.

• Brunerova L, Bartakova H, Jankovska M, Cieslarova B, Hulek P, Kozak T, Andel M 2004 The Budd-Chiari syndrome in a patient with primary thrombocythemia treated with interferon alfa and transjugular portosystemic shunt. Cas. Lek. Cesk. 143: 198-201.

• Bucciarelli S, Cervera R, Espinosa G, Gomez-Puerta JA, Ramos-Casals M, Font J 2006 Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors. Autoimmun. Rev. 6: 72-75.

• Bucciarelli S, Espinosa G, Asherson RA, Cervera R, Claver G, Gomez-Puerta JA, Ramos-Casals M, Ingelmo M, Font J 2006 The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patients. Ann. Rheum. Dis. 65: 81-86. *

• Bucciarelli S, Espinosa G, Cervera R, Erkan D, Gomez-Puerta JA, Ramos-Casals M, Font J, Asherson RA 2006 Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients. Arthritis Rheum. 54: 2568-2576. *

• Caliz R, Atsumi T, Kondeatis E, Amengual O, Khamashta MA, Vaughan RW, Lanchbury JS, Hughes GR 2001 HLA class II gene polymorphisms in antiphospholipid syndrome: haplotype analysis in 83 Caucasoid patients. Rheumatology (Oxford) 40: 31-36. *

• Canpolat N, Topal N, Civilibal M, Caliskan S, Sever L, Kasapcopur O, Baserer T, Arisoy N 2008 A case of catastrophic antiphospholipid syndrome in an adolescent girl with parvovirus B19 infection. Clin. Pediatr. (Phila.) 47: 593-597.

• Carta G, Iovenitti P, Falciglia K 2005 Recurrent miscarriage associated with antiphospholipid antibodies: prophylactic treatment with low-dose aspirin and fish oil derivates. Clin. Exp. Obstet. Gynecol. 32: 49-51.

• Carvalho JF, Blank M, Kiss E, Tarr T, Amital H, Shoenfeld Y 2007 Anti-vitamin D, vitamin D in SLE: preliminary results. Ann. N. Y. Acad. Sci. 1109: 550-557.

• Castellino G, Govoni M, Prandini N, Limpido G, Bernardi S, Campione D, Lanza F, Trotta F 2007 Thrombocytosis in systemic lupus erythematosus: a possible clue to autosplenectomy? J. Rheumatol. 34: 1497-1501.

• Cervera R 2008 Lessons from the "Euro-Phospholipid" project. Autoimmun. Rev. 7: 174-178.

• Cervera R, Asherson RA 2005 Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics. Immunobiology 210: 735-741.

• Cervera R, Asherson RA, Acevedo ML, Gomez-Puerta JA, Espinosa G, De La Red G, Gil V, Ramos-Casals M, Garcia-Carrasco M, Ingelmo M, Font J 2004 Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients. Ann. Rheum. Dis. 63: 1312-1317. *

• Cervera R, Balasch J 2008 Bidirectional effects on autoimmunity and reproduction. Hum. Reprod. Update 14: 359-366.

• Cervera R, Font J, Gomez-Puerta JA, Espinosa G, Cucho M, Bucciarelli S, Ramos-Casals M, Ingelmo M, Piette JC, Shenfeld Y, Asherson RA, Caps Registry Project Group MO 2005 Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. Ann. Rheum. Dis. 64: 1205-1209. *

• Cesarman-Maus G, Rios-Luna NP, Deora AB, Huang B, Villa R, Del Carmen Cravioto M, Alarcon-Segovia D, Sanchez-Guerrero J, Hajjar KA 2006 Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome. Blood 107: 4375-4382. *

• Cholongitas E, Mavrogiannaki A, Papaioannou C, Karagiannis S, Papatheodoridis GV 2004 Pericarditis and possible antiphospholipid syndrome on primary biliary cirrhosis. Ann. Hepatol. 3: 167-168. *

• Chung L, Flyckt RL, Colon I, Shah AA, Druzin M, Chakravarty EF 2006 Outcome of pregnancies complicated by systemic sclerosis and mixed connective tissue disease. Lupus 15: 595-589.

• Cook HT, Botto M 2006 Mechanisms of disease: the complement system and the pathogenesis of systemic lupus erythematosus. Nat. Clin. Pract. Rheumatol. 2: 330-337. *

• Coroi M, Bontas E, Defranceschi M, Bartos D, Dorobantu M 2007 Ocular manifestations of antiphospholipid (Hughes') syndrome - minor features? Oftalmologia 51: 16-22.

• Crowther MA 2005 Antiphospholipid antibody syndrome: recent findings on managing this challenging condition. Cleve. Clin. J. Med. 72: 245-249. *

• Cucnik S, Bozic B, Kveder T, Tomsic M, Rozman B 2005 Avidity of anti-beta2-glycoprotein I and thrombosis or pregnancy loss in patients with antiphospholipid syndrome. Ann. N. Y. Acad. Sci. 1051: 141-147. *

• Czaja AJ 2007 Autoimmune liver disease and rheumatic manifestations. Curr. Opin. Rheumatol. 19: 74-80.

• Czaja AJ 2002 Autoimmune liver disease. Curr. Opin. Gastroenterol. 18: 334-344.

• Czlonkowska A, Sliwinska A 2007 Multiple sclerosis and antiphospholipid syndrome - difficulties in differential diagnostics. Pol. Arch. Med. Wewn. 117: S28-S32.

• D'Cruz DP, Khamashta MA, Hughes GR 2007 Systemic lupus erythematosus. Lancet 369: 587-596. *

• Dafer RM, Biller J 2008 Antiphospholipid syndrome: role of antiphospholipid antibodies in neurology. Hematol. Oncol. Clin. North Am. 22: 95-105.

• Darnige L 2006 Laboratory diagnosis of antiphospholipid syndrome. Rev. Med. Interne. 27: 296-301.

• de Groot PG, Derksen RH 2004 Pathophysiology of antiphospholipid antibodies. Neth. J. Med. 62: 267-272. *

• de Laat B, Derksen RH, Mackie IJ, Roest M, Schoormans S, Woodhams BJ, de Groot PG, van Heerde WL 2006 Annexin A5 polymorphism (-1C>T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndrome. Ann. Rheum. Dis. 65: 1468-1472. *

• de Laat B, Wu XX, van Lummel M, Derksen RH, de Groot PG, Rand JH 2007 Correlation between antiphospholipid antibodies that recognize domain I of beta2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5. Blood 109: 1490-1494. *

• de Larranaga GF, Harris N, Pierangeli SS, Alonso BS, Schroder T, Fainboim H 2000 Low prevalence of autoimmune antiphospholipid antibodies in hepatic diseases. Medicina (B. Aires) 60: 919-922.

• De-Leon-Bojorge B, Zaltzman-Girsevich S, Ortega-Salgado A, Prieto-Patron A, Cordoba-Cordoba R, Yamazaki-Nakashimada M 2006 Thrombotic microangiopathy involving the gallbladder as an unusual manifestation of systemic lupus erythematosus and antiphospholipid syndrome: case report and review of the literature. World J. Gastroenterol. 12: 7206-7209. *

• Demarco P, Singh I, Weinstein A 2006 Management of the antiphospholipid syndrome. Curr. Rheumatol. Rep. 8: 114-120.

• Dias Gonzalez F, Pedreira Magalhaes F, Pontes Vilas Boas Freitas A, Castro Lima Filho H, Santiago MB 2006 Lipodermatosclerosis in patients with diffuse connective tissue diseases. Eur. J. Intern. Med. 17: 288-289.

• Digiovanni JJ, Nair P 2006 Spontaneous recovery of sudden sensorineural hearing loss: possible association with autoimmune disorders. J. Am. Acad. Audiol. 17: 498-505.

• Dima-Cozma C, Pandele GI, Rezus E, Constantinescu A, Mihailovici MS 2005 Systemic lupus erythematosus with neurologic onset and secondary antiphospholIpid syndrome. A case study. Rev. Med. Chir. Soc. Med. Nat. Iasi. 109: 254-258.

• Distler JH, Huber LC, Gay S, Distler O, Pisetsky DS 2006 Microparticles as mediators of cellular cross-talk in inflammatory disease. Autoimmunity 39: 683-690.

• Dourakis SP, Michael AE, Papanikolaou IS, Nomikou E, Thalassinou P, Hadziyannis SJ 2001 Autoimmune hepatitis associated with the antiphospholipid syndrome. Eur. J. Gastroenterol. Hepatol. 13: 591-593.

• Dupuy d'Angeac A, Stefas I, Graafland H, de Lamotte F, Rucheton M, Palais C, Eriksson AK, Bosc P, Rose C, Chicheportiche R 2006 Biotinylation of glycan chains of beta2 glycoprotein I induces dimerisation of the molecule and its detection by the human autoimmune anti-cardiolipin antibody EY2C9. Biochem. J. 393: 117-127. *

• Edwards CJ, Syddall H, Jameson K, Williams EL, Polosa R, Goswami R, Dennison EM, Arden NK, Cooper C; The Hertfordshire Cohort Study Group 2008 The presence of anticardiolipin antibodies in adults may be influenced by infections in infancy. QJM 101: 41-47.

• El-Bostany EA, El-Ghoroury EA, El-Ghafar EA 2008 Anti-beta2-glycoprotein I in childhood immune thrombocytopenic purpura. Blood Coagul. Fibrinolysis 19: 26-31.

• Erkan D, Harrison MJ, Levy R, Peterson M, Petri M, Sammaritano L, Unalp-Arida A, Vilela V, Yazici Y, Lockshin MD 2007 Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. Arthritis Rheum. 56: 2382-2391. *

• Erre GL, Pardini S, Faedda R, Passiu G 2008 Effect of rituximab on clinical and laboratory features of antiphospholipid syndrome: a case report and a review of literature. Lupus 17: 50-55.

• Espinola-Zavaleta N, Alexanderson-Rosas E, Granados N, Elena Soto M, Amigo MC 2006 Myocardial perfusion defects in patients with autoimmune diseases: a prospective study. Analysis of two diagnostic tests. Lupus 15: 38-43.

• Espinosa G, Bucciarelli S, Asherson RA, Cervera R 2008 Morbidity and mortality in the catastrophic antiphospholipid syndrome: pathophysiology, causes of death, and prognostic factors. Semin. Thromb. Hemost. 34: 290-294.

• Faricelli R, Esposito S, Toniato E, Flacco M, Conti P, Martinotti S, Robuffo I 2008 A new diagnostic approach to better identify antiphospholipid syndrome. Int. J. Immunopathol. Pharmacol. 21: 387-392.

• Fauchais AL, Lambert M, Launay D, Michon-Pasturel U, Queyrel V, Nguyen N, Hebbar M, Hachulla E, Devulder B, Hatron PY 2004 Antiphospholipid antibodies in primary Sjogren's syndrome: prevalence and clinical significance in a series of 74 patients. Lupus 13: 245-248.

• Fernandez-Fernandez FJ, Rivera-Gallego A, de la Fuente-Aguado J, Perez-Fernandez S, Munoz-Fernandez D 2006 Antiphospholipid syndrome mimicking multiple sclerosis in two patients. Eur. J. Intern. Med. 17: 500-502.

• Fernando MM, Isenberg DA 2008 Conversion of discoid lupus to antiphospholipid syndrome and SLE. Nat. Clin. Pract. Rheumatol. 4: 106-110.

• Ferrera F, Cava AL, Rizzi M, Hahn BH, Indiveri F, Filaci G 2007 Gene vaccination for the induction of immune tolerance. Ann. N. Y. Acad. Sci. 1110: 99-111.

• Figueredo MA, Rodriguez A, Ruiz-Yague M, Romero M, Fernandez-Cruz A, Gomez-de la Concha E, Patino R 2006 Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome. J. Rheumatol. 33: 1980-1986.

• Fojtik Z 2006 Antiphospholipid syndrome. Vnitr. Lek. 52: 718-725.

• Font J, Ramos-Casals M, Brito-Zeron P, Nardi N, Ibanez A, Suarez B, Jimenez S, Tassies D, Garcia-Criado A, Ros E, Sentis J, Reverter JC, Lozano F 2007 Association of mannose-binding lectin gene polymorphisms with antiphospholipid syndrome, cardiovascular disease and chronic damage in patients with systemic lupus erythematosus. Rheumatology (Oxford) 46: 76-80. *

• Franchini M 2006 The antiphospholipid syndrome: an update. Clin. Lab. 52: 11-17.

• Frieri M 2003 Identification of masqueraders of autoimmune disease in the office. Allergy Asthma Proc. 24: 421-429.

• Gabeta S, Norman GL, Gatselis N, Liaskos C, Papamichalis PA, Garagounis A, Zachou K, Rigopoulou EI, Dalekos GN 2008 IgA anti-b2GPI antibodies in patients with autoimmune liver diseases. J. Clin. Immunol. Jun 13 [Epub ahead of print]. *

• Galli M, Barbui T 2005 Antiphospholipid syndrome: clinical and diagnostic utility of laboratory tests. Semin. Thromb. Hemost. 31: 17-24.

• Galrao L, Brites C, Atta ML, Atta A, Lima I, Gonzalez F, Magalhaes F, Santiago M 2007 Antiphospholipid antibodies in HIV-positive patients. Clin. Rheumatol. 26: 1825-1830. *

• Ganor Y, Goldberg-Stern H, Blank M, Shoenfeld Y, Dobrynina LA, Kalashnikova L, Levite M 2005 Antibodies to glutamate receptor subtype 3 (GluR3) are found in some patients suffering from epilepsy as the main disease, but not in patients whose epilepsy accompanies antiphospholipid syndrome or Sneddon's syndrome. Autoimmunity 38: 417-424.

• Gaya DR, Oien KA, Stanley AJ, Morris AJ 2005 Bleeding gastric varices and antiphospholipid syndrome. Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 156-159. *

• Gezer S 2003 Antiphospholipid syndrome. Dis. Mon. 49: 696-741.

• Gidwani P, Segal E, Shanske A, Driscoll C 2007 Chorea associated with antiphospholipid antibodies in a patient with Kabuki syndrome. Am. J. Med. Genet. A. 143: 1338-1341.

• Girschick HJ, Guilherme L, Inman RD, Latsch K, Rihl M, Sherer Y, Shoenfeld Y, Zeidler H, Arienti S, Doria A 2008 Bacterial triggers and autoimmune rheumatic diseases. Clin. Exp. Rheumatol. 26: S12-S17.

• Goldstein R, Moulds JM, Smith CD, Sengar DP 1996 MHC studies of the primary antiphospholipid antibody syndrome and of antiphospholipid antibodies in systemic lupus erythematosus. J. Rheumatol. 23: 1173-1179.

• Gomez-Puerta JA, Burlingame RW, Cervera R 2008 Anti-chromatin (anti-nucleosome) antibodies: diagnostic and clinical value. Autoimmun. Rev. 7: 606-611.

• Gomez-Puerta JA, Cervera R, Espinosa G, Bucciarelli S, Font J 2006 Pregnancy and puerperium are high susceptibility periods for the development of catastrophic antiphospholipid syndrome. Autoimmun. Rev. 6: 85-88.

• Gomez-Puerta JA, Martin H, Amigo MC, Aguirre MA, Camps MT, Cuadrado MJ, Hughes GR, Khamashta MA 2005 Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus? Medicine (Baltimore) 84: 225-230.

• Gorki H, Malinovski V, Stanbridge RD 2008 The antiphospholipid syndrome and heart valve surgery. Eur. J. Cardiothorac. Surg. 33: 168-181.

• Gorshtein A, Levy Y 2007 Orthopedic involvement in antiphospholipid syndrome. Clin. Rev. Allergy Immunol. 32: 167-171.

• Graffin B, Goutorbe P, Poyet R, Raymond A, Paris JF, Carli P 2007 Multi-organ failures during septic shock from Escherichia coli urinary tract infection: catastrophic antiphospholipid syndrome? Rev. Med. Interne. 28: 52-55.

• Guerin J, Casey E, Feighery C, Jackson J 1999 Anti-beta 2-glycoprotein I antibody isotype and IgG subclass in antiphospholipid syndrome patients. Autoimmunity 31: 109-116.

• Guerin J, Smith O, White B, Sweetman G, Feighery C, Jackson J 1998 Antibodies to prothrombin in antiphospholipid syndrome and inflammatory disorders. Br. J. Haematol. 102: 896-902.

• Gupta D, Mirza N 2008 Systemic lupus erythematosus, celiac disease and antiphospholipid antibody syndrome: a rare association. Rheumatol. Int. 28: 1179-1180. *

• Hadjigogos K, Marinaki P 2003 Autoimmune hepatitis and the antiphospholipid antibody syndrome. A case report. Panminerva Med. 45: 223-224.

• Han BK, Inaganti K, Fahmi S, Reimold A 2004 Polyarteritis nodosa complicated by catastrophic antiphospholipid syndrome. J. Clin. Rheumatol. 10: 210-213.

• Haram K, Gjelland K 2007 Foetal growth restriction. Tidsskr. Nor. Laegeforen. 127: 2665-2669.

• Harel M, Aron-Maor A, Sherer Y, Blank M, Shoenfeld Y 2005 The infectious etiology of the antiphospholipid syndrome: links between infection and autoimmunity. Immunobiology 210: 743-747. *

• Harel M, Shoenfeld Y 2006 Predicting and preventing autoimmunity, myth or reality? Ann. N. Y. Acad. Sci. 1069: 322-345. *

• Hartung K, Seelig HP 2007 Laboratory diagnostics of systemic autoimmune diseases: Part II. Rheumatoid arthritis and vasculopathies. Z. Rheumatol. 66: 225-238.

• Hashimoto N, Iwasaki T, Sekiguchi M, Takatsuka H, Okamoto T, Hashimoto T, Sano H 2004 Autologous hematopoietic stem cell transplantation for refractory antiphospholipid syndrome causing myocardial necrosis. Bone Marrow Transplant. 33: 863-866. *

• Hawkins CA, Gatenby PA, Tuck R, Danta G, Andrews C 2006 Cerebrovascular disease associated with antiphospholipid antibodies: more questions than answers. J. Autoimmune Dis. 3: 3. *

• Heshmat NM, El-Kerdany TH 2007 Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosus. Pediatr. Allergy Immunol. 18: 346-353.

• Hills FA, Abrahams VM, Gonzalez-Timon B, Francis J, Cloke B, Hinkson L, Rai R, Mor G, Regan L, Sullivan M, Lam EW, Brosens JJ 2006 Heparin prevents programmed cell death in human trophoblast. Mol. Hum. Reprod. 12: 237-243.

• Hodak E, David M 2007 Primary anetoderma and antiphospholipid antibodies - review of the literature. Clin. Rev. Allergy Immunol. 32: 162-166.

• Hoffman M, Burke M, Fried M, Turner D, Yosipov Y, Yust I 1997 Primary biliary cirrhosis associated with antiphospholipid syndrome. Isr. J. Med. Sci. 33: 681-686.

• Hoppensteadt DA, Walenga JM 2008 The relationship between the antiphospholipid syndrome and heparin-induced thrombocytopenia. Hematol. Oncol. Clin. North Am. 22: 1-18.

• Horita T, Merrill JT 2004 Genetics of antiphospholipid syndrome. Curr. Rheumatol. Rep. 6: 458-462.

• Hsiao GR, Wolf RE, Kimpel DL 2001 Intravenous immunoglobulin to prevent recurrent thrombosis in the antiphospholipid syndrome. J. Clin. Rheumatol. 7: 336-339.

• Hughes G 2007 Hughes syndrome: the antiphospholipid syndrome-a clinical overview. Clin. Rev. Allergy Immunol. 32: 3-12.

• Hulstein JJ, Lenting PJ, de Laat B, Derksen RH, Fijnheer R, de Groot P 2007 Beta2-Glycoprotein I inhibits von Willebrand factor-dependent platelet adhesion and aggregation. Blood 110: 1483-1491. *

• Ieko M, Nakabayashi T, Tarumi T, Yoshida M, Naito S, Atsumi T, Koike T 2006 Phosphatidylserine-dependent anti-prothrombin antibody as a new marker for the diagnosis of antiphospholipid syndrome. Rinsho Byori 54: 256-262.

• Ikeda Y, Yagi S, Yamaguchi H, Fujimura M, Hashizume S, Aihara K, Akaike M, Azuma H, Matsumoto T 2006 Intra-vascular ultrasound findings of diffuse coronary atherosclerotic change in systemic lupus erythematosus with secondary antiphospholipid syndrome. Circ. J. 70: 1082-1085. *

• Ilkgul O, Icoz G, Dayangac M, Tokat Y, Ozutemiz O 2004 A case of antiphospholipid antibody syndrome with Budd-Chiari and colonic ulcers complicated with gastrointestinal hemorrhage. Turk. J. Gastroenterol. 15: 115-116. *

• Innocencio RM, Romaldini JH, Ward LS 2004 Thyroid autoantibodies in autoimmune diseases. Medicina (B. Aires) 64: 227-230.

• Ioannou Y, Lambrianides A, Cambridge G, Leandro MJ, Edwards JC, Isenberg DA 2008 B cell depletion therapy for patients with systemic lupus erythematosus results in a significant drop in anticardiolipin antibody titres. Ann. Rheum. Dis. 67: 425-426.

• Jara LJ, Medina G, Vera-Lastra O 2007 Systemic antiphospholipid syndrome and atherosclerosis. Clin. Rev. Allergy Immunol. 32: 172-177.

• Jones DS 2005 Multivalent compounds for antigen-specific B cell tolerance and treatment of autoimmune diseases. Curr. Med. Chem. 12: 1887-1904.

• Jorge O, Jorge A, Camus G 2008 Celiac disease associated with antiphospholipid syndrome. Rev. Esp. Enferm. Dig. 100: 102-103.

• Junge U, Wienke J, Schuler A 2001 Acute Budd-Chiari syndrome, portal and splenic vein thrombosis in a patient with ulcerative colitis associated with antiphospholipid antibodies and protein C deficiency. Z. Gastroenterol. 39: 845-852.

• Jy W, Tiede M, Bidot CJ, Horstman LL, Jimenez JJ, Chirinos J, Ahn YS 2008 Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies. Thromb. Res. 121: 319-325.

• Kahn P, Ramanujam M, Bethunaickan R, Huang W, Tao H, Madaio MP, Factor SM, Davidson A 2008 Prevention of murine antiphospholipid syndrome by BAFF blockade. Arthritis Rheum. 58: 2824-2834. *

• Kalashnikova LA 2004 Ischemic stroke at the young age: the role of antiphospholipid antibodies. Angiol. Sosud. Khir. 10: 8-12.

• Kamboh MI, Sanghera DK, Mehdi H, Nestlerode CS, Chen Q, Khalifa O, Naqvi A, Manzi S, Bunker CH 2004 Single nucleotide polymorphisms in the coding region of the apolipoprotein H (beta2-glycoprotein I) gene and their correlation with the protein polymorphism, anti-beta2glycoprotein I antibodies and cardiolipin binding. Ann. Hum. Genet. 68: 285-299. *

• Karassa FB, Trikalinos TA, Ioannidis JP 2004 The role of FcgammaRIIA and IIIA polymorphisms in autoimmune diseases. Biomed. Pharmacother. 58: 286-291.

• Karoui S, Sellami MK, Laatar AB, Zitouni M, Matri S, Laadhar L, Fekih M, Boubaker J, Makni S, Filali A 2007 Prevalence of anticardiolipin and anti-beta(2)-glycoprotein I antibodies in celiac disease. Dig. Dis. Sci. 52: 1096-1100. *

• Katayama Y, Kohriyama K, Kirizuka K, Nishizaki H, Fujii H, Tanji Y 2000 Sjogren's syndrome complicated with autoimmune hepatitis and antiphospholipid antibody syndrome. Intern. Med. 39: 73-76. *

• Keane PA, Ravikumar K, O'Shea SI, Cleary PE 2006 Anti-beta2 glycoprotein 1 and the anti-phospholipid syndrome. Am. J. Ophthalmol. 142: 701-702. *

• Khamashta MA 2006 Systemic lupus erythematosus and pregnancy. Best Pract. Res. Clin. Rheumatol. 20: 685-694.

• Khubchandani RP, D'Souza S 2003 Antiphospholipid antibody syndrome as a cause of Budd-Chiari syndrome. Indian Pediatr. 40: 907-908.

• Kim WJ, Hong YK, Yoo WH 2008 Epidural hematoma mimicking transverse myelitis in a patient with primary antiphospholipid syndrome. Rheumatol. Int. 28: 709-712.

• Kinjo K, Terabe H, Ogawa M, Takeda H, Cho D, Hoshino S, Miyahira T, Oshiro M 2008 A case of catastrophic antiphospholipid syndrome presenting with acute respiratory distress syndrome as the initial manifestation. Rheumatol. Int. Jul 24 [Epub ahead of print]. *

• Kisiel E, Kryczka W 2007 Antiphospholipid antibodies with HCV infection. Innocent proteins or risk factor? Przegl. Lek. 64: 521-524.

• Klein R, Goller S, Bianchi L 2003 Nodular regenerative hyperplasia (NRH) of the liver - a manifestation of 'organ-specific antiphospholipid syndrome'? Immunobiology 207: 51-57.

• Kling C, Steinmann J, Westphal E, Magez J, Kabelitz D 2006 Adverse effects of intradermal allogeneic lymphocyte immunotherapy: acute reactions and role of autoimmunity. Hum. Reprod. 21: 429-435.

• Klumb EM, de Andrade MC, Jesus NR, Campani C, Campos CF, Levy RA, Albuquerque E, Cervantes V 2007 Primary antiphospholipid nephropathy beginning during pregnancy. Rheumatol. Int. 27: 289-293. *

• Kobayashi K, Lopez LR, Shoenfeld Y, Matsuura E 2005 The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis. Ann. N. Y. Acad. Sci. 1051: 442-454.

• Koike T, Bohgaki M, Amengual O, Atsumi T 2007 Antiphospholipid antibodies: lessons from the bench. J. Autoimmun. 28: 129-133.

• Krause I, Blank M, Cervera R, Font J, Matthias T, Pfeiffer S, Wies I, Fraser A, Shoenfeld Y 2007 Cross-reactive epitopes on beta2-glycoprotein-I and Saccharomyces cerevisiae in patients with the antiphospholipid syndrome. Ann. N. Y. Acad. Sci. 1108: 481-488.

• Krause I, Blank M, Fraser A, Lorber M, Stojanovich L, Rovensky J, Shoenfeld Y 2005 The association of thrombocytopenia with systemic manifestations in the antiphospholipid syndrome. Immunobiology 210: 749-754.

• Krause I, Leibovici L, Blank M, Shoenfeld Y 2007 Clusters of disease manifestations in patients with antiphospholipid syndrome demonstrated by factor analysis. Lupus 16: 176-180.

• Kumar V, Ali SR, Konrad S, Zwirner J, Verbeek JS, Schmidt RE, Gessner JE 2006 Cell-derived anaphylatoxins as key mediators of antibody-dependent type II autoimmunity in mice. J. Clin. Invest. 116: 512-520. *

• Kurniadhi D, Pujiwati, Wijaya LK, Setiyohadi B, Atmakusuma D 2007 Cerebral thrombosis in systemic lupus erythematosus with the antibody antiphospholipid syndrome. Acta Med. Indones. 39: 82-85.

• Kuwana M, Matsuura E, Kobayashi K, Okazaki Y, Kaburaki J, Ikeda Y, Kawakami Y 2005 Binding of beta2-glycoprotein I to anionic phospholipids facilitates processing and presentation of a cryptic epitope that activates pathogenic autoreactive T cells. Blood 105: 1552-1557. *

• Kuyucu S, Argin A, Kuyucu N, Ozen S 2007 Systemic lupus erythematosus presenting with pseudotumor cerebri: a rare association. Turk. J. Pediatr. 49: 98-101.

• Lachaud S, Soriani MH, Delmont E, Budai M, Desnuelle C, Lebrun C 2007 Mills' syndrome: a rare clinical entity. Rev. Neurol. (Paris) 163: 335-340.

• Le Thi Huong D, Wechsler B, Piette JC 2008 Pregnancy and systemic lupus erythematosus. Rev. Med. Interne. 29: 725-730.

• Leitinger N 2008 The role of phospholipid oxidation products in inflammatory and autoimmune diseases: evidence from animal models and in humans. Subcell. Biochem. 49: 325-350.

• Levy Y, Almog O, Gorshtein A, Shoenfeld Y 2006 The environment and antiphospholipid syndrome. Lupus 15: 784-790.

• Liaskos C, Rigopoulou E, Zachou K, Georgiadou S, Gatselis N, Papamihali R, Dalekos GN 2005 Prevalence and clinical significance of anticardiolipin antibodies in patients with type 1 autoimmune hepatitis. J. Autoimmun. 24: 251-260.

• Lieby P, Poindron V, Roussi S, Klein C, Knapp AM, Garaud JC, Cerutti M, Martin T, Pasquali JL 2004 Pathogenic antiphospholipid antibody: an antigen selected needle in a haystack. Blood 104: 1711-1715. *

• Lim W, Crowther MA, Eikelboom JW 2006 Management of antiphospholipid antibody syndrome: a systematic review. JAMA 295: 1050-1057. *

• Lima G, Soto-Vega E, Atisha-Fregoso Y, Sanchez-Guerrero J, Vallejo M, Vargas-Alarcon G, Llorente L 2007 MCP-1, RANTES, and SDF-1 polymorphisms in Mexican patients with systemic lupus erythematosus. Hum. Immunol. 68: 980-985.

• Lima I, Melo A, Brandi IV, Costa O, Santiago M 2007 Lupoid sclerosis: what is the role of antiphospholipid antibodies? J. Clin. Rheumatol. 13: 85-86.

• Linares P, Vivas S, Olcoz JL 2005 Autoimmune hepatitis associated with the antiphospholipid syndrome and ulcerative colitis. Eur. J. Intern. Med. 16: 376.

• Lincz LF, Adams MJ, Scorgie FE, Thom J, Baker RI, Seldon M 2007 Polymorphisms of the tissue factor pathway inhibitor gene are associated with venous thromboembolism in the antiphospholipid syndrome and carriers of factor V Leiden. Blood Coagul. Fibrinolysis 18: 559-564.

• Lopez LR, Salazar-Paramo M, Palafox-Sanchez C, Hurley BL, Matsuura E, Garcia-De La Torre I 2006 Oxidized low-density lipoprotein and beta2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis. Lupus 15: 80-86.

• Lopez-Pedrera C, Cuadrado MJ, Herandez V, Buendia P, Aguirre MA, Barbarroja N, Torres LA, Villalba JM, Velasco F, Khamashta M 2008 Proteomic analysis in monocytes of antiphospholipid syndrome patients: deregulation of proteins related to the development of thrombosis. Arthritis Rheum. 58: 2835-2844. *

• Lunardi C, Tinazzi E, Bason C, Dolcino M, Corrocher R, Puccetti A 2008 Human parvovirus B19 infection and autoimmunity. Autoimmun. Rev. Aug 9 [Epub ahead of print].

• Magro CM, Dyrsen ME, Crowson AN 2008 Acute infectious id panniculitis/panniculitic bacterid: a distinctive form of neutrophilic lobular panniculitis. J. Cutan. Pathol. Aug 4 [Epub ahead of print].

• Maksimowicz-McKinnon K, Mandell BF 2004 Understanding valvular heart disease in patients with systemic autoimmune diseases. Cleve. Clin. J. Med. 71: 881-885.

• Marai I, Zandman-Goddard G, Shoenfeld Y 2004 The systemic nature of the antiphospholipid syndrome. Scand. J. Rheumatol. 33: 365-372. *

• Martin-Toutain I, Piette JC, Diemert MC, Faucher C, Jobic L, Ankri A 2007 High prevalence of antibodies to platelet factor 4 heparin in patients with antiphospholipid antibodies in absence of heparin-induced thrombocytopenia. Lupus 16: 79-83.

• Matsushita S, Fujisao S, Nishimura Y 1996 Molecular mechanisms underlying HLA-DR-associated susceptibility to autoimmunity. Int. J. Cardiol. 54 Suppl.: S81-S90.

• Matsuura E, Hughes GR, Khamashta MA 2008 Oxidation of LDL and its clinical implication. Autoimmun. Rev. 7: 558-566.

• Matsuura E, Kobayashi K, Lopez LR 2008 Preventing autoimmune and infection triggered atherosclerosis for an enduring healthful lifestyle. Autoimmun. Rev. 7: 214-222.

• Mavragani CP, Patronas N, Dalakas M, Moutsopoulos HM 2007 Ill-defined neurological syndromes with autoimmune background: a diagnostic challenge. J. Rheumatol. 34: 341-345.

• Maya R, Gershwin ME, Shoenfeld Y 2008 Hepatitis B virus (HBV) and autoimmune disease. Clin. Rev. Allergy Immunol. 34: 85-102. *

• McMahon MA, Keogan M, O'Connell P, Kearns G 2006 The prevalence of antiphospholipid antibody syndrome among systemic lupus erythematosus patients. Ir. Med. J. 100: 296-298.

• Medina G, Vera-Lastra O, Angeles U, Jara LJ 2005 Mono-organic versus multi-organic involvement in primary antiphospholipid syndrome. Ann. N. Y. Acad. Sci. 1051: 304-312.

• Meglic A, Grosek S, Benedik-Dolnicar M, Avcin T 2008 Atypical haemolytic uremic syndrome complicated by microangiopathic antiphospholipid-associated syndrome. Lupus 17: 842-845.

• Mehta LR, Samuelsson MK, Kleiner AK, Goodman AD, Anolik JH, Looney RJ, Schmid SR 2008 Neuromyelitis optica spectrum disorder in a patient with systemic lupus erythematosus and anti-phospholipid antibody syndrome. Mult. Scler. 14: 425-427.

• Mejia-Romero R, Garcia-Carrasco M, Galarza-Maldonado C, Santos P, Mendoza-Pinto C, Escarcega RO, Salinas-Saldivar S, Soto-Vega E, Lopez-Colombo A, Cervera R 2008 Primary antiphospholipid syndrome in Latin American mestizo patients: clinical and immunologic characteristics and comparison with European patients. Clin. Rheumatol. 27: 891-897. *

• Merkel PA, Polisson RP, Chang Y, Skates SJ, Niles JL 1997 Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann. Intern. Med. 126: 866-873.

• Meroni PL 2008 Pathogenesis of the antiphospholipid syndrome: an additional example of the mosaic of autoimmunity. J. Autoimmun. 30: 99-103. *

• Meroni PL, Raschi E, Testoni C, Parisio A, Borghi MO 2004 Innate immunity in the antiphospholipid syndrome: role of Toll-like receptors in endothelial cell activation by antiphospholipid antibodies. Autoimmun. Rev. 3: 510-515.

• Merrill JT, Asherson RA 2006 Catastrophic antiphospholipid syndrome. Nat. Clin. Pract. Rheumatol. 2: 81-89. *

• Metzger J, von Landenberg P, Kehrel M, Buhl A, Lackner KJ, Luppa PB 2007 Biosensor analysis of beta2-glycoprotein I-reactive autoantibodies: evidence for isotype-specific binding and differentiation of pathogenic from infection-induced antibodies. Clin. Chem. 53: 1137-1143.

• Micheloud D, Sanchez-Ramon S, Carbone J, Rodriguez Molina JJ, Fernandez-Cruz E, Lopez-Longo FJ, Rodriguez-Mahou M 2005 Discordance between anti-beta2-glycoprotein-I and anti-cardiolipin antibodies in patients with clinical criteria of antiphospholipid syndrome. Clin. Exp. Rheumatol. 23: 525-528.

• Miesbach W, Gokpinar B, Gilzinger A, Claus D, Scharrer I 2005 Predictive role of hs-C-reactive protein in patients with antiphospholipid syndrome. Immunobiology 210: 755-760.

• Miesbach W, Matthias T, Scharrer I 2005 Identification of thrombin antibodies in patients with antiphospholipid syndrome. Ann. N. Y. Acad. Sci. 1050: 250-256. *

• Miesbach W, Scharrer I 2004 The antiphospholipid syndrome. Dtsch. Med. Wochenschr. 129: 2547-2552.

• Miesbach W, Scharrer I, Asherson R 2006 Thrombotic manifestations of the antiphospholipid syndrome in patients with malignancies. Clin. Rheumatol. 25: 840-844. *

• Miyajima S, Taguchi Y, Tanaka E, Inoue T, Sakuramoto M, Minakuchi M, Maeda Y, Maniwa K, Tanizawa K, Okamoto M, Takeda T 2006 A case of pulmonary adenocarcinoma accompanied by minimal change nephrotic syndrome, antiphospholipid syndrome and warm-type autoimmune hemolytic anemia. Nihon Kokyuki Gakkai Zasshi 44: 631-635.

• Motta M, Tincani A, Lojacono A, Faden D, Gorla R, Airo P, Neri F, Gasparoni A, Ciardelli L, de Silvestri A, Marconi M, Chirico G 2004 Neonatal outcome in patients with rheumatic disease. Lupus 13: 718-723.

• Motta S, Monti M 2007 Photodynamic therapy-a promising treatment option for autoimmune skin ulcers: a case report. Photochem. Photobiol. Sci. 6: 1150-1151. *

• Mundo J, Peris P, Monegal A, Navasa M, Cervera R, Guaniabens N 2006 Multifocal avascular necrosis after liver transplantation: an unusual presentation of the antiphospholipid syndrome. Lupus 15: 304-307.

• Murdaca G, Colombo BM, Sprecacenere B, Caiti M, Massa G, Picciotto A, Ceppa P, Puppo F 2007 Autoimmune intrahepatic cholangiopathy associated with antiphospholipid antibody syndrome. Eur. J. Gastroenterol. Hepatol. 19: 910-912.

• Muscal E, Brey RL 2008 Neurologic manifestations of the antiphospholipid syndrome: integrating molecular and clinical lessons. Curr. Rheumatol. Rep. 10: 67-73.

• Musso M, Porretto F, Crescimanno A, Bondi F, Polizzi V, Scalone R, Mariani G 1998 Autologous peripheral blood stem and progenitor (CD34+) cell transplantation for systemic lupus erythematosus complicated by Evans syndrome. Lupus 7: 492-494.

• Musuruana JL, Cavallasca JA 2008 Polyarteritis nodosa complicated by antiphospholipid syndrome. South. Med. J. 101: 419-421.

• Nakamura M, Tanaka Y, Satoh T, Kawai M, Hirakata M, Kaburaki J, Kawakami Y, Ikeda Y, Kuwana M 2006 Autoantibody to CD40 ligand in systemic lupus erythematosus: association with thrombocytopenia but not thromboembolism. Rheumatology (Oxford) 45: 150-156. *

• Nicolo D, Monestier M 2004 Antiphospholipid antibodies and atherosclerosis. Clin. Immunol. 112: 183-189. *

• Nucera C, Vaccaro M, Moleti M, Priolo C, Tortorella G, Angioni A, Ientile R, Violi MA, Loda M, Trimarchi F, Vermiglio F 2006 Antiphospholipid antibodies syndrome (APS) associated with hyperhomocysteinemia related to MTHFR gene C677T and A1298C heterozygous mutations in a young man with idiopathic hypoparathyroidism (DiGeorge syndrome). J. Clin. Endocrinol. Metab. 91: 2021-2026. *

• Olech E, Merrill JT 2006 The prevalence and clinical significance of antiphospholipid antibodies in rheumatoid arthritis. Curr. Rheumatol. Rep. 8: 100-108.

• Oliver-Minarro D, Sanchez-Ramon S, Rodriguez-Mahou M, Alvarez S, Fernandez-Cruz E 2007 Isolated type 5 antimitochondrial autoantibodies are associated with a history of thrombocytopenia and fetal loss. Fertil. Steril. 87: 976.e17-e18.

• Olowu W 2007 Childhood-onset systemic lupus erythematosus. J. Natl. Med. Assoc. 99: 777-784.

• Orbach H, Zandman-Goddard G, Amital H, Barak V, Szekanecz Z, Szucs G, Danko K, Nagy E, Csepany T, Carvalho JF, Doria A, Shoenfeld Y 2007 Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann. N. Y. Acad. Sci. 1109: 385-400. *

• Ortego-Centeno N, Callejas-Rubio JL, Fernandez MG, Camello MG 2006 Transient global amnesia in a patient with high and persistent levels of antiphospholipid antibodies. Clin. Rheumatol. 25: 407-408.

• Ostrowski RA, Robinson JA 2008 Antiphospholipid antibody syndrome and autoimmune diseases. Hematol. Oncol. Clin. North Am. 22: 53-65.

• Ou Y, Zhu P, Zhu X, Gu JY, Liu J, DU JW, Zhang Y, Liu HX, Zhuang X 2006 Characteristics of T cell receptors recognizing antiphospholipid syndrome associated antigens. Zhongguo Shi Yan Xue Ye Xue Za Zhi 14: 1156-1159.

• Pagnoux C 2007 Plasma exchange for systemic lupus erythematosus. Transfus. Apher. Sci. 36: 187-193.

• Palomo I, Pinochet C, Alarcon M, Sandoval R, Gonzalez J, Monsalves F, Forastiero R 2006 Prevalence of antiphospholipid antibodies in Chilean patients with rheumatoid arthritis. J. Clin. Lab. Anal. 20: 190-194.

• Paran D, Fireman E, Elkayam O 2004 Pulmonary disease in systemic lupus erythematosus and the antiphospholpid syndrome. Autoimmun. Rev. 3: 70-75. *

• Parikh T, Shifteh K, Lipton ML, Bello JA, Brook AL 2007 Deep brain reversible encephalopathy: association with secondary antiphospholipid antibody syndrome. AJNR Am. J. Neuroradiol. 28: 76-78. *

• Park JM, Shin JI, Shin YH, Kim DS, Lee JS, Kim MJ, Lee SK, Lee DY 2007 Catastrophic antiphospholipid syndrome in a 7-year-old girl. Clin. Rheumatol. 26: 1011-1013. *

• Passam FH, Krilis SA 2004 Laboratory tests for the antiphospholipid syndrome: current concepts. Pathology 36: 129-138. *

• Pelletier S, Landi B, Piette JC, Ekert P, Coutellier A, Desmoulins C, Fadlallah JP, Herson S, Valla D 1994 Antiphospholipid syndrome as the second cause of non-tumorous Budd-Chiari syndrome. J. Hepatol. 21: 76-80.

• Peng SW, Mitchell JP 2006 Thromboendarterectomy as treatment in the antiphospholipid syndrome. MedGenMed. 8: 7.

• Pengo V, Biasiolo A, Bison E, Chantarangkul V, Tripodi A; on behalf of the participating centres of the Italian Federation of Anticoagulation Clinics (FCSA) 2007 Antiphospholipid antibody ELISAs: survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-beta(2)-Glycoprotein I activity. Thromb. Res. 120: 127-133. *

• Pengo V, Biasiolo A, Pegoraro C, Cucchini U, Noventa F, Iliceto S 2005 Antibody profiles for the diagnosis of antiphospholipid syndrome. Thromb. Haemost. 93: 1147-1152.

• Pengo V, Ruffatti A 2007 Laboratory diagnosis of antiphospholipid syndrome. Reumatismo 59: 187-191. *

• Pennings MT, VAN Lummel M, Derksen RH, Urbanus RT, Romijn RA, Lenting PJ, DE Groot PG 2006 Interaction of beta-glycoprotein I with members of the low density lipoprotein receptor family. J. Thromb. Haemost. 4: 1680-1690.

• Pierangeli SS, Chen PP, Gonzalez EB 2006 Antiphospholipid antibodies and the antiphospholipid syndrome: an update on treatment and pathogenic mechanisms. Curr. Opin. Hematol. 13: 366-375.

• Pierangeli SS, Vega-Ostertag ME, Gonzalez EB 2007 New targeted therapies for treatment of thrombosis in antiphospholipid syndrome. Expert Rev. Mol. Med. 9: 1-15.

• Pierangeli SS, Vega-Ostertag ME, Raschi E, Liu X, Romay-Penabad Z, De Micheli V, Galli M, Moia M, Tincani A, Borghi MO, Nguyen-Oghalai T, Meroni PL 2007 Toll-like receptor 4 is involved in antiphospholipid-mediated thrombosis: in vivo studies. Ann. Rheum. Dis. 66: 1327-1333.

• Porta C, Caporali R, Montecucco C 2005 Autoimmunity in thrombotic thrombocytopenic purpura. Semin. Thromb. Hemost. 31: 633-640.

• Pottel H, Wiik A, Locht H, Gordon T, Roberts-Thomson P, Abraham D, Goossens K, Dobbels C, De Bosschere K, Hulstaert F, Meheus L 2004 Clinical optimization and multicenter validation of antigen-specific cut-off values on the INNO-LIA ANA update for the detection of autoantibodies in connective tissue disorders. Clin. Exp. Rheumatol. 22: 579-588.

• Praseedom RK, Jalan R, Allan P, McGilchrist A, Roddie H, Madhavan KK 2000 Combined hepatic artery and segmental portal vein occlusion in antiphospholipid syndrome. Dig. Surg. 17: 405-406.

• Presotto F, Fornasini F, Betterle C, Federspil G, Rossato M 2005 Acute adrenal failure as the heralding symptom of primary antiphospholipid syndrome: report of a case and review of the literature. Eur. J. Endocrinol. 153: 507-514. *

• Quehenberger P, Wagner O 2005 Laboratory diagnosis of the lupus anticoagulants. Thromb. Haemost. 25: 50-54.

• Racine A, Nahon S, Jouannaud V, Caugant H, Lesgourgues B 2008 Portal vein thrombosis in a patient with quiescent Crohn's disease associated with hyperhomocysteinemia and antiphospholipid antibody syndrome 1-yr after an ileocecal resection. Am. J. Gastroenterol. 103: 499-501.

• Rahman A, Lambrianides A, Giles I 2008 Structure-function relationships in anti-DNA and anti-phospholipid antibodies and their relevance to the pathogenesis of disease. Curr. Rheumatol. Rev. 4: 2-11.

• Ramos-Casals M, Brito-Zeron P, Font J 2007 The overlap of Sjogren's syndrome with other systemic autoimmune diseases. Semin. Arthritis Rheum. 36: 246-255. *

• Ramos-Casals M, Font J 2005 Extrahepatic manifestations in patients with chronic hepatitis C virus infection. Curr. Opin. Rheumatol. 17: 447-455.

• Ramos-Casals M, Jara LJ, Medina F, Rosas J, Calvo-Alen J, Mana J, Anaya JM, Font J; THE HISPAMEC STUDY GROUP 2005 Systemic autoimmune diseases co-existing with chronic hepatitis C virus infection (the HISPAMEC Registry): patterns of clinical and immunological expression in 180 cases. J. Intern. Med. 257: 549-557. *

• Ramos-Casals M, Nardi N, Brito-Zeron P, Aguilo S, Gil V, Delgado G, Bove A, Font J 2006 Atypical autoantibodies in patients with primary Sjogren syndrome: clinical characteristics and follow-up of 82 cases. Semin. Arthritis Rheum. 35: 312-321. *

• Rand JH 2007 The antiphospholipid syndrome. Hematology Am. Soc. Hematol. Educ. Program 2007: 136-142. *

• Rashtak S, Pittelkow MR 2008 Skin involvement in systemic autoimmune diseases. Curr. Dir. Autoimmun. 10: 344-358.

• Redecha P, Franzke CW, Ruf W, Mackman N, Girardi G 2008 Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome. J. Clin. Invest. Sep 18 [Epub ahead of print]. *

• Reinstein E, Shoenfeld Y 2007 Antiphospholipid syndrome and cancer. Clin. Rev. Allergy Immunol. 32: 184-187.

• Reyes H, Dearing L, Bick RL, Shoenfeld Y, Peter JB 1995 Laboratory diagnosis of antiphospholipid syndromes. Clin. Lab. Med. 15: 85-108.

• Roberts JR, Finger DR 2004 Catastrophic antiphospholipid syndrome; a "CATASTROPHIC" case of systemic lupus erythematosus. Hawaii Med. J. 63: 362-364.

• Robertson B, Greaves M 2006 Antiphospholipid syndrome: an evolving story. Blood Rev. 20: 201-212.

• Roccatello D, Rossi D, Giachino O, Bazzan M, Mazzucco G 2007 Antiphospholipid syndrome and kidney. G. Ital. Nefrol. 24: 111-120.

• Rodriguez Carballeira M, Gomez de Argila I, Salas Caudevila A, More Monreal J 2007 Renal microangiopathy with IgA deposits in a patient with antiphospholipid syndrome and primary sclerosing cholangitis. Med. Clin. (Barc.) 128: 37-38.

• Romero Arauz JF, Garcia Alonso Lopez A, Gonzalez AL, Rivera Velasquez P, Ayala Mendez JA 2006 Antiphospholipid syndrome and pregnancy. Ginecol. Obstet. Mex. 74: 367-375.

• Rozin AP 2007 From molecular mimicry to cross-reactivity or pathogen expansion? A hypothesis. Clin. Rheumatol. 26: 285-288. *

• Ruckert A, Glimm H, Lubbert M, Grullich C 2008 Successful treatment of life-threatening Evans syndrome due to antiphospholipid antibody syndrome by rituximab-based regimen: a case with long-term follow-up. Lupus 17: 757-760.

• Saadoun D, Cazals-Hatem D, Denninger MH, Boudaoud L, Pham BN, Mallet V, Condat B, Briere J, Valla D 2004 Association of idiopathic hepatic sinusoidal dilatation with the immunological features of the antiphospholipid syndrome. Gut 53: 1516-1519. *

• Saeki R, Kaneko S, Terasaki S, Unoura M, Ogino H, Wakabayashi T, Kawara S, Nakanuma Y, Kobayashi K 1993 Mixed types of chronic active hepatitis and primary biliary cirrhosis associated with the anti-phospholipid antibody syndrome: a case report. Hepatogastroenterology 40: 499-501.

• Sahin M, Duzgun N, Ercan Tunc S, Tutkak H 2007 Antibodies to beta(2)-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus. Clin. Biochem. 40: 526-530. *

• Sahin M, Duzgun N, Tunc SE, Tutkak H 2007 Clinical manifestations and antiphosphatidylserine antibodies in patients with systemic lupus erythematosus: is there an association? Clin. Rheumatol. 26: 154-160. *

• Salle V, Maziere JC, Smail A, Cevallos R, Maziere C, Fuentes V, Tramier B, Makdassi R, Choukroun G, Vittecoq O, Goeb V, Ducroix JP 2008 Anti-annexin II antibodies in systemic autoimmune diseases and antiphospholipid syndrome. J. Clin. Immunol. 28: 291-297. *

• Salobir B, S abovic M, Hojnik M, Cucnik S, Kveder T 2007 Anti-beta2-glycoprotein I antibodies of IgM class are linked to thrombotic disorders in young women without autoimmune disease. Immunobiology 212: 193-199.

• Sanchez ML, Katsumata K, Atsumi T, Romero FI, Bertolaccini ML, Funke A, Amengual O, Kondeatis E, Vaughan RW, Cox A, Hughes GR, Khamashta MA 2004 Association of HLA-DM polymorphism with the production of antiphospholipid antibodies. Ann. Rheum. Dis. 63: 1645-1648. *

• Sanmarco M, Gayet S, Alessi MC, Audrain M, de Maistre E, Gris JC, de Groot PG, Hachulla E, Harlé JR, Sié P, Boffa MC 2007 Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies. Thromb. Haemost. 97: 949-954.

• Santiago M, Martinelli R, Reis MG, Reis EA, Ko A, Fontes RD, Silva MP, Nascimento EG, de Jesus R, Pierangeli S, Espinola R, Gharavi A 2004 Diagnostic performance of anti-beta2 glycoprotein I and anticardiolipin assays for clinical manifestations of the antiphospholipid syndrome. Clin. Rheumatol. 23: 485-489.

• Santiago MB, Paz O 2007 Rare association of antiphospholipid syndrome and Takayasu arteritis. Clin. Rheumatol. 26: 821-822. *

• Satta N, Dunoyer-Geindre S, Reber G, Fish RJ, Boehlen F, Kruithof EK, de Moerloose P 2007 The role of TLR2 in the inflammatory activation of mouse fibroblasts by human antiphospholipid antibodies. Blood 109: 1507-1514. *

• Schenkein HA, Best AM, Brooks CN, Burmeister JA, Arrowood JA, Kontos MC, Tew JG 2007 Anti-cardiolipin and increased serum adhesion nolecule levels in patients with aggressive periodontitis. J. Periodontol. 78: 459-466.

• Scherer EM, Zwick MB, Teyton L, Burton DR 2007 Difficulties in eliciting broadly neutralizing anti-HIV antibodies are not explained by cardiolipin autoreactivity. AIDS 21: 2131-2139.

• Schmidt R, Scheuermann EH, Viertel A, Geiger H, Scharrer I 1999 Antiphospholipid antibody syndrome. Med. Klin. (Munich) 94: 93-100.

• Schuchmann S, Dorner T 2007 Antiphospholipid syndrome 2007: current aspects of laboratory diagnostics and their therapeutic consequences. Z. Rheumatol. 66: 198-205.

• Schwartz N, Shoenfeld Y, Barzilai O, Cervera R, Font J, Blank M, Yacobi S, Patlas N, Cohen A, Mevorach D, Ornoy A 2007 Reduced placental growth and hCG secretion in vitro induced by antiphospholipid antibodies but not by anti-Ro or anti-La: studies on sera from women with SLE/PAPS. Lupus 16: 110-120.

• Seinturier C, Imbert B, Ponard D, Drouet C, Debru JL 2005 Sneddon syndrome with anti-mitochondrial type M5 antibodies. Presse. Med. 34: 1011-1012.

• Serra CR, Rodrigues SH, Silva NP, Sztajnbok FR, Andrade LE 1999 Clinical significance of anticardiolipin antibodies in juvenile idiopathic arthritis. Clin. Exp. Rheumatol. 17: 375-380.

• Shah AA, Higgins JP, Chakravarty EF 2007 Thrombotic microangiopathic hemolytic anemia in a patient with SLE: diagnostic difficulties. Nat. Clin. Pract. Rheumatol. 3: 357-362. *

• Sherer Y, Blank M, Shoenfeld Y 2007 Antiphospholipid syndrome (APS): where does it come from? Best Pract. Res. Clin. Rheumatol. 21: 1071-1078.

• Sherer Y, Shoenfeld Y 2006 Mechanisms of disease: atherosclerosis in autoimmune diseases. Nat. Clin. Pract. Rheumatol. 2: 99-106. *

• Shin SY, Lee JM 2006 A case of multiple cranial nerve palsies as the initial ophthalmic presentation of antiphospholipid syndrome. Korean J. Ophthalmol. 20: 76-78.

• Shirai J, Ida A, Jiang Y, Sanokawa-Akakura R, Miura Y, Yan K, Hamano Y, Hirose S, Shirai T 1999 Genetic polymorphism of murine tissue plasminogen activator associated with antiphospholipid syndrome. Genes Immun. 1: 130-136. *

• Shoenfeld Y 2007 APS - more systemic disease than SLE. Clin. Rev. Allergy Immunol. 32: 129-130.

• Shoenfeld Y, Katz U 2005 IVIg therapy in autoimmunity and related disorders: our experience with a large cohort of patients. Autoimmunity 38: 123-137.

• Shoenfeld Y, Twig G, Katz U, Sherer Y 2008 Autoantibody explosion in antiphospholipid syndrome. J. Autoimmun. 30: 74-83.

• Shovman O, Gilburd B, Barzilai O, Langevitz P, Shoenfeld Y 2007 Novel insights into associations of antibodies against cardiolipin and beta2-glycoprotein i with clinical features of antiphospholipid syndrome. Clin. Rev. Allergy Immunol. 32: 145-152.

• Shternshis IuA, Sveranovskaia VV, Samoilikov PV 2005 Epitope mimicry and its role in the development of autoimmune reactions. Zh. Mikrobiol. Epidemiol. Immunobiol. 1: 96-100.

• Sibilia J 2006 Treatment of systemic lupus erythematosus in 2006. Joint Bone Spine 73: 591-598.

• Singh A, Blank M, Shoenfeld Y, Illges H 2008 Antiphospholipid syndrome patients display reduced titers of soluble CD21 in their sera irrespective of circulating anti-beta2-glycoprotein-I autoantibodies. Rheumatol. Int. 28: 661-665. *

• Soares Rolim AM, Castro M, Santiago MB 2006 Neonatal antiphospholipid syndrome. Lupus 15: 301-303.

• Sodin-Semrl S, Zigon P, Cucnik S, Kveder T, Blinc A, Tomsic M, Rozman B 2006 Serum amyloid A in autoimmune thrombosis. Autoimmun. Rev. 6: 21-27.

• Soltesz P, Szekanecz Z, Kiss E, Shoenfeld Y 2007 Cardiac manifestations in antiphospholipid syndrome. Autoimmun. Rev. 6: 379-386.

• Soy M, Oktun MT, Tuncbilek N, Ermantas N, Okten O, Altinay G, Turgut B 2006 Nocardiosis in a patient with primary anti-phospholipid syndrome. Rheumatol. Int. 26: 461-464. *

• Spencer HL 2004 Primary antiphospholipid syndrome as a new cause of autoimmune pancreatitis. Gut 53: 468. *

• Stevens HP, Ostlere LS, Rustin MH 1994 Systemic lupus erythematosus in association with ulcerative colitis: related autoimmune diseases. Br. J. Dermatol. 130: 385-389.

• Su BY, Su CY, Yu SF, Chen CJ 2007 Incidental discovery of high systemic lupus erythematosus disease activity associated with cytomegalovirus viral activity. Med. Microbiol. Immunol. 196: 165-170. *

• Swadzba J, Iwaniec T, Szczeklik A, Musial J 2007 Revised classification criteria for antiphospholipid syndrome and the thrombotic risk in patients with autoimmune diseases. J. Thromb. Haemost. 5: 1883-1889.

• Swadzba J, Iwaniec T, Wilanska J, Musial J 2006 Antiphospholipid syndrome in autoimmune diseases. Pol. Arch. Med. Wewn. 115: 432-437.

• Swadzba J, Sanak M, Iwaniec T, Dziedzina S, Musial J 2006 Valine/leucine247 polymorphism of beta2-glycoprotein I in patients with antiphospholipid syndrome: lack of association with anti-beta2-glycoprotein I antibodies. Lupus 15: 218-222.

• Szanto A, Kiss E, Sas A, Szegedi G, Zeher M 2005 Association of systemic lupus erythematosus and Sjogren's syndrome. Orv. Hetil. 146: 2533-2538.

• Szanto A, Szodoray P, Kiss E, Kapitany A, Szegedi G, Zeher M 2006 Clinical, serologic, and genetic profiles of patients with associated Sjogren's syndrome and systemic lupus erythematosus. Hum. Immunol. 67: 924-930.

• Szekanecz Z, Szucs G, Szanto S, Koch AE 2005 Chemokines in rheumatic diseases. Curr. Drug Targets 6: 91-102.

• Szyper-Kravitz M, Altman A, de Carvalho JF, Bellisai F, Galeazzi M, Eshet Y, Shoenfeld Y 2008 Coexistence of the antiphospholipid syndrome and abdominal aortic aneurysm. Isr. Med. Assoc. J. 10: 48-51. *

• Takahashi F, Toba M, Takahashi K, Tominaga S, Sato K, Morio Y, Nakao Y, Tajima K, Miura K, Uekusa T, Fukuchi Y 2006 Pulmonary sarcoidosis and antiphospholipid syndrome. Respirology 11: 506-508. *

• Tanaka A, Igarashi M, Kakinuma M, Oh-i T, Koga M, Okuda T 2001 The occurrence of various collagen diseases in one family: a sister with ISSc, PBC, APS, and SS and a brother with systemic lupus erythematosus. J. Dermatol. 28: 547-653.

• Tanaka H, Umekawa T, Kikukawa T, Toyoda N 2002 Autoimmune hepatitis complicated with antiphospholipid syndrome in pregnancy. Am. J. Reprod. Immunol. 47: 142-145.

• Tanasescu R, Nicolau A, Caraiola S, Ticmeanu M, Cojocaru IM, Frasineanu A, Ionescu R, Hristea A, Ene A, Anghel D, Tanasescu R, Baicus C 2007 Antiphospholipid antibodies and migraine: a retrospective study of 428 patients with inflammatory connective tissue diseases. Rom. J. Intern. Med. 45: 355-363.

• Tanne D, Katzav A, Beilin O, Grigoriadis NC, Blank M, Pick CG, Landenberg PV, Shoenfeld Y, Chapman J 2008 Interaction of inflammation, thrombosis, aspirin and enoxaparin in CNS experimental antiphospholipid syndrome. Neurobiol. Dis. 30: 56-64.

• Targonska-Stepniak B, Majdan M, Suszek D, Laskowska K 2006 Overlap syndrome autoimmune hepatitis and primary biliary cirrhosis associated with antiphospholipid syndrome. Pol. Merkur. Lekarski. 21: 480-483.

• Tarr T, Lakos G, Bhattoa HP, Shoenfeld Y, Szegedi G, Kiss E 2007 Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients. Lupus 16: 39-45.

• Tarr T, Lakos G, Bhattoa HP, Szegedi G, Shoenfeld Y, Kiss E 2007 Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus. Lupus 16: 324-328.

• Tarr T, Muzes G, Pitlik E, Lakos G, Csepany T, Soltesz P, Zeher M, Szegedi G, Kiss E 2005 Is the primary antiphospholipid syndrome a forerunner of SLE? Orv. Hetil. 146: 203-207.

• Tenedios F, Erkan D, Lockshin MD 2005 Cardiac involvement in the antiphospholipid syndrome. Lupus 14: 691-696.

• Thaler M, Buhl A, Welter H, Schreiegg A, Kehrel M, Alber B, Metzger J, Luppa PB 2008 Biosensor analyses of serum autoantibodies: application to antiphospholipid syndrome and systemic lupus erythematosus. Anal. Bioanal. Chem. Aug 31 [Epub ahead of print]. *

• Theodoridou A, Settas L 2006 Demyelination in rheumatic diseases. J. Neurol. Neurosurg. Psychiatry 77: 290-295.

• Theodoridou A, Settas L 2008 Demyelination in rheumatic diseases. Postgrad. Med. J. 84: 127-132.

• Tincani A, Biasini-Rebaioli C, Cattaneo R, Riboldi P 2005 Nonorgan specific autoantibodies and heart damage. Lupus 14: 656-659.

• Tincani A, Bompane D, Danieli E, Doria A 2006 Pregnancy, lupus and antiphospholipid syndrome (Hughes syndrome). Lupus 15: 156-160.

• Tincani A, Rebaioli CB, Frassi M, Taglietti M, Gorla R, Cavazzana I, Faden D, Taddei F, Lojacono A, Motta M, Trepidi L, Meroni P, Cimaz R, Ghirardello A, Doria A, Pisoni MP, Muscara M, Brucato A; Pregnancy Study Group of Italian Society of Rheumatology 2005 Pregnancy and autoimmunity: maternal treatment and maternal disease influence on pregnancy outcome. Autoimmun. Rev. 4: 423-428.

• Tirosh A, Mandel D, Mimouni FB, Zimlichman E, Shochat T, Kochba I 2006 Autoimmune diseases in asthma. Ann. Intern. Med. 144: 877-883. *

• Tomb R, Maalouf E, Attoui S 2008 Cutaneous nodular lesions and antiphospholipid syndrome. Ann. Dermatol. Venereol. 135: 484-487.

• Toubi E, Kessel A, Shoenfeld Y 2005 High-dose intravenous immunoglobulins: an option in the treatment of systemic lupus erythematosus. Hum. Immunol. 66: 395-402.

• Tsantes AE, Nikolopoulos GK, Bagos PG, Rapti E, Mantzios G, Kapsimali V, Travlou A 2007 Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and venous thrombosis. A meta-analysis. Thromb. Haemost. 97: 907-913.

• Tsutsumi A, Hayashi T, Chino Y, Mamura M, Goto D, Matsumoto I, Ito S, Sumida T 2006 Significance of antiprothrombin antibodies in patients with systemic lupus erythematosus: clinical evaluation of the antiprothrombin assay and the antiphosphatidylserine/prothrombin assay, and comparison with other antiphospholipid antibody assays. Mod. Rheumatol. 16: 158-164. *

• Twito O, Reshef T, Ellis MH 2006 C-reactive protein level as a predictor of transient vs. sustained anticardiolipin antibody positivity. Eur. J. Haematol. 76: 206-209.

• Ulander VM, Stefanovic V, Rinta-Kiikka I, Kaaja R 2006 Pregnancy-associated recurrent liver necrosis in patient with antiphospholipid syndrome. Lupus 15: 889-891.

• Ulcova-Gallova Z 2005 Antiphospholipid antibodies and reproductive failure. Chem. Immunol. Allergy 88: 139-149.

• Urbanus RT, Derksen RH, de Groot PG 2008 Current insight into diagnostics and pathophysiology of the antiphospolipid syndrome. Blood Rev. 22: 93-105.

• Uthman I, Khamashta M 2007 The abdominal manifestations of the antiphospholipid syndrome. Rheumatology (Oxford) 46: 1641-1647.

• Valesini G, Alessandri C 2005 New facet of antiphospholipid antibodies. Ann. N. Y. Acad. Sci. 1051: 487-497. *

• Vantelon JM, Godeau B, Andre C, Bierling P 2000 Screening for autoimmune markers is unnecessary during follow-up of adults with autoimmune thrombocytopenic purpura and no autoimmune markers at onset. Thromb. Haemost. 83: 42-45.

• Vasoo S, Sangle S, Zain M, D'Cruz D, Hughes G 2005 Orthopaedic manifestations of the antiphospholipid (Hughes) syndrome. Lupus 14: 339-345.

• Vasugi Z, Danda D 2006 Systemic lupus erythematosis with antiphospholipid antibody syndrome: a mimic of Buerger's disease. J. Postgrad. Med. 52: 132-133. *

• Vazquez-Del Mercado M, Martin-Marquez BT, Petri MH, Martinez-Garcia EA, Munoz-Valle JF 2006 Molecular mechanisms in normal pregnancy and rheumatic diseases. Clin. Exp. Rheumatol. 24: 707-712.

• Vega-Ostertag ME, Pierangeli SS 2007 Mechanisms of aPL-mediated thrombosis: effects of aPL on endothelium and platelets. Curr. Rheumatol. Rep. 9: 190-197.

• Vilisaar J, Wilson M, Niepel G, Blumhardt LD, Constantinescu CS 2005 A comparative audit of anticardiolipin antibodies in oligoclonal band negative and positive multiple sclerosis. Mult. Scler. 11: 378-380.

• Villamil A, Sorkin E, Basta MC, Mysler E, Macias S, Pekolj J, Ciardullo M, Eleta F, de Santibanes E, Allievi A, Gadano A 2003 Catastrophic antiphospholipid syndrome complicating orthotopic liver transplantation. Lupus 12: 140-143.

• Vlachoyiannopoulos PG, Samarkos M 2004 Peripheral vascular disease in antiphospholipid syndrome. Thromb. Res. 114: 509-519.

• Vlachoyiannopoulos PG, Samarkos M, Sikara M, Tsiligros P 2007 Antiphospholipid antibodies: laboratory and pathogenetic aspects. Crit. Rev. Clin. Lab. Sci. 44: 271-338.

• Vogrinc Z, Trbojevic-Cepe M, Coen D, Vitale K, Stavljenic-Rukavina A 2005 Apolipoprotein H (apoH)-dependent autoantibodies and apoH protein polymorphism in selected patients showing lupus anticoagulant activity. Clin. Chem. Lab. Med. 43: 17-21. *

• Von Landenberg P, Lehmann HW, Knoll A, Dorsch S, Modrow S 2003 Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection. Arthritis Rheum. 48: 1939-1947. *

• Waldman MA, Callen JP 2005 Pyoderma gangrenosum preceding the diagnosis of systemic lupus erythematosus. Dermatology 210: 64-67.

• Wallace DJ 2008 Autoinflammatory disorders of childhood: continued major breakthroughs. Curr. Rheumatol. Rev. 4: 1.

• Ware Branch D, Eller AG 2006 Antiphospholipid syndrome and thrombosis. Clin. Obstet. Gynecol. 49: 861-874.

• Warren JB, Silver RM 2004 Autoimmune disease in pregnancy: systemic lupus erythematosus and antiphospholipid syndrome. Obstet. Gynecol. Clin. North Am. 31: 345-372.

• Weiler H 2008 Tracing the molecular pathogenesis of antiphospholipid syndrome. J. Clin. Invest. Sep 18 [Epub ahead of print]. *

• Weissman A, Coplan NL 2006 Antiphospholipid antibody syndrome and acute stent thrombosis. Rev. Cardiovasc. Med. 7: 244-246.

• Wielosz E, Majdan M, Zychowska I, Jeleniewicz R 2008 Coexistence of five autoimmune diseases: diagnostic and therapeutic difficulties. Rheumatol. Int. 28: 919-923. *

• Wild EJ, Tabrizi SJ 2007 The differential diagnosis of chorea. Pract. Neurol. 7: 360-373.

• Wilson WA 1996 Histocompatibility genes in antiphospholipid antibody syndrome. Lupus 5: 259-262.

• Wu S, Stephenson MD 2006 Obstetrical antiphospholipid syndrome. Semin. Reprod. Med. 24: 40-53.

• Yamasaki Y, Narain S, Yoshida H, Hernandez L, Barker T, Hahn PC, Sobel ES, Segal MS, Richards HB, Chan EK, Reeves WH, Satoh M 2007 Autoantibodies to RNA helicase A: a new serologic marker of early lupus. Arthritis Rheum. 56: 596-604. *

• Yasuda S, Atsumi T, Matsuura E, Kaihara K, Yamamoto D, Ichikawa K, Koike T 2005 Significance of valine/leucine(247) polymorphism of beta(2)-glycoprotein I in antiphospholipid syndrome: increased reactivity of anti-beta(2)-glycoprotein I autoantibodies to the valine(247) beta(2)-glycoprotein I variant. Arthritis Rheum. 52: 212-218. *

• Yasuda S, Bohgaki M, Atsumi T, Koike T 2005 Pathogenesis of antiphospholipid antibodies: impairment of fibrinolysis and monocyte activation via the p38 mitogen-activated protein kinase pathway. Immunobiology 210: 775-780.

• Zachou K, Liaskos C, Rigopoulou E, Gabeta S, Papamichalis P, Gatselis N, Georgiadou S, Dalekos GN 2006 Presence of high avidity anticardiolipin antibodies in patients with autoimmune cholestatic liver diseases. Clin. Immunol. 119: 203-212. *

• Zandman-Goddard G, Chapman J, Shoenfeld Y 2007 Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. Semin. Arthritis Rheum. 36: 297-315. *

• Zandman-Goddard G, Tweezer-Zaks N, Shalev T, Levy Y, Ehrenfeld M, Langevitz P 2007 A novel overlap syndrome: systemic sclerosis associated with antiphospholipid syndrome - a case series. Ann. N. Y. Acad. Sci. 1108: 497-504.

• Zurgil N, Bakimer R, Moutsopoulos HM, Tzioufas AG, Youinou P, Isenberg DA, Scheinberg M, Kveder T, Rozman B, Luderschmidt C, et al 1992 Antimitochondrial (pyruvate dehydrogenase) autoantibodies in autoimmune rheumatic diseases. J. Clin. Immunol. 12: 201-209.

Number of references = 373

www psc-literature.org